• Channels
    • All News
    • Premium Content
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

The ven­ture crew at Mubadala are up­ping their biotech cre­ation game, tak­ing care­ful aim at a new fron­tier in drug ...

18 minutes ago
Bioregnum
Discovery

Roche and Lil­ly team up to de­vel­op blood test to de­tect ear­ly signs of Alzheimer's

55 minutes ago
R&D

89bio’s PhII da­ta add to quick suc­ces­sion of NASH read­outs as field seeks turn­around

1 hour ago
R&D

A $123M Flare will get Third Rock on­col­o­gy biotech in­to the clin­ic this year

1 hour ago
Financing
Startups

Ex­clu­sive: Af­ter get­ting his drug back, Lan­dos founder as­sem­bles new start­up for the big PhI­II test

2 hours ago
Startups

NIH re­jects an­oth­er at­tempt to 'march-in' on Astel­las' prostate can­cer drug over ex­ces­sive price

14 hours ago
Pharma
Law

FDA warns Proc­ter & Gam­ble over NyQuil la­bel's in­gre­di­ent list­ings

16 hours ago
FDA+
Manufacturing

FTC says patent bat­tle over Parkin­son's drug could have 'sig­nif­i­cant im­pli­ca­tion­s' for pa­tients

16 hours ago
Pharma
Law

No­vo Nordisk re­mains un­der UK scruti­ny as MHRA con­ducts its own re­view in 'in­cred­i­bly rare' case

17 hours ago
Pharma
Marketing

Growth hor­mone from No­vo Nordisk is in short­age over man­u­fac­tur­ing de­lays

17 hours ago
Pharma
Manufacturing

PhRMA calls for more di­verse in­fra­struc­ture up­grades to US emer­gency tri­als frame­work

17 hours ago
Pharma

Biden signs law re­quir­ing more de­clas­si­fi­ca­tions on Covid-19's ori­gins

18 hours ago
Coronavirus

Im­mat­ics an­nounces mul­ti­ple pipeline changes with lat­est fi­nan­cial re­sults

18 hours ago
R&D

Mar­ket­ingRx roundup: What could a US Tik­Tok ban mean for phar­ma? Pfiz­er, Lil­ly lead phar­ma March Mad­ness ad­ver­tis­ers

19 hours ago
Pharma
Marketing

Chat­G­PT with phar­ma da­ta de­buts for med­ical meet­ings, be­gin­ning with AACR

19 hours ago
AI
Pharma

Roche un­veils long-term da­ta from piv­otal spinal mus­cu­lar at­ro­phy tri­al

20 hours ago
R&D
Pharma

Al­tim­mune’s shares halved af­ter in­ter­im look at PhII weight loss drug da­ta

20 hours ago
R&D

Af­ter rais­ing $140M, SPAC will take biotech pub­lic with a frac­tion of planned funds

21 hours ago
Financing

Who are the women break­ing bar­ri­ers in drug de­vel­op­ment? Nom­i­nate them for End­points' an­nu­al re­port

21 hours ago
People

In­cyte touts mid-stage da­ta for new JAK in­hibitor but stops short of se­lect­ing PhI­II dose

Yesterday
R&D

Kite's head of re­search leaves for Flag­ship start­up Sonata

Yesterday
People
Startups

Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

Yesterday
People

One fi­nal push: EU phar­ma in­dus­try group de­mands com­pe­ti­tion check on in­com­ing leg­isla­tive over­haul

Yesterday
Pharma
Law

Karuna to raise $400M in mar­ket a day af­ter pos­i­tive read­out of schiz­o­phre­nia drug

Yesterday
Financing
1234 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET